中外医疗
中外醫療
중외의료
CHINA FOREIGN MEDICAL TREATMENT
2015年
23期
60-61
,共2页
剖宫产手术%剔除子宫肌瘤%安全性分析
剖宮產手術%剔除子宮肌瘤%安全性分析
부궁산수술%척제자궁기류%안전성분석
Cesarean section%Uterine myomectomy%Analysis of safety
目的:分析探讨剖宫产手术中剔除子宫肌瘤的安全性。方法随机选取该院2010年3月—2012年3月间该院接诊并收治的正常剖宫产患者和剖宫产同时行子宫肌瘤剔除术的患者各45例。根据临床资料和随访记录进行剖宫产手术中剔除子宫肌瘤的安全性回顾分析。结果肌瘤组手术时间、术中出血量分别为(72.7±16.4)min、(289.7±56.7)mL较正常组的(50.3±14.3)min、(233.4±38.9)mL比较差异有统计学意义(P<0.05);两组在手术并发症及新生儿Apgar评分上差异无统计学意义(P>0.05)。结论在剖宫产手术中同时剔除子宫肌瘤安全可靠的治疗方法,既取得了很好的治疗效果,未出现严重的不良反应或合并症,又避免了再次开刀的切除子宫肌瘤的痛苦,受到了患者及家属的普遍好评和欢迎。值得在临床工作中大力推广。
目的:分析探討剖宮產手術中剔除子宮肌瘤的安全性。方法隨機選取該院2010年3月—2012年3月間該院接診併收治的正常剖宮產患者和剖宮產同時行子宮肌瘤剔除術的患者各45例。根據臨床資料和隨訪記錄進行剖宮產手術中剔除子宮肌瘤的安全性迴顧分析。結果肌瘤組手術時間、術中齣血量分彆為(72.7±16.4)min、(289.7±56.7)mL較正常組的(50.3±14.3)min、(233.4±38.9)mL比較差異有統計學意義(P<0.05);兩組在手術併髮癥及新生兒Apgar評分上差異無統計學意義(P>0.05)。結論在剖宮產手術中同時剔除子宮肌瘤安全可靠的治療方法,既取得瞭很好的治療效果,未齣現嚴重的不良反應或閤併癥,又避免瞭再次開刀的切除子宮肌瘤的痛苦,受到瞭患者及傢屬的普遍好評和歡迎。值得在臨床工作中大力推廣。
목적:분석탐토부궁산수술중척제자궁기류적안전성。방법수궤선취해원2010년3월—2012년3월간해원접진병수치적정상부궁산환자화부궁산동시행자궁기류척제술적환자각45례。근거림상자료화수방기록진행부궁산수술중척제자궁기류적안전성회고분석。결과기류조수술시간、술중출혈량분별위(72.7±16.4)min、(289.7±56.7)mL교정상조적(50.3±14.3)min、(233.4±38.9)mL비교차이유통계학의의(P<0.05);량조재수술병발증급신생인Apgar평분상차이무통계학의의(P>0.05)。결론재부궁산수술중동시척제자궁기류안전가고적치료방법,기취득료흔호적치료효과,미출현엄중적불량반응혹합병증,우피면료재차개도적절제자궁기류적통고,수도료환자급가속적보편호평화환영。치득재림상공작중대력추엄。
Objective To analyze the safety of uterine myomectomy in cesarean section. Methods 45 patients undergoing cesarean section and 45 other patients undergoing uterine myomectomy in cesarean section admitted to our hospital during March 2012 and March 2012 were randomly selected, and the safety of the operation was retrospectively analyzed based on their clinical data and follow-up records. Results The operation duration and intraoperative blood loss were (72.7±16.4)min,(289.7±56.7)ml in 45 par-turient women with hysteromyoma, while those were 50.3±14.3)min,(233.4±38.9)in the 45 normal parturient women, and the dif-ferences were statistically significant, P<0.05; but there were no statistically significant differences in complications and neonatal Apgar score between the two groups (P>0.05). Conclusion Uterine myomectomy in cesarean section is worthy of promotion due to its high satisfactory based on higher safety, good effect, and less adverse reaction or complications.